Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    From the city to the bush: Increases in patient co-payments for medicines have impacted on medicine use across Australia

    Access Status
    Fulltext not available
    Authors
    Kemp, A.
    Glover, J.
    Preen, D.
    Bulsara, M.
    Semmens, James
    Roughead, E.
    Date
    2013
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Kemp, Anna and Glover, John and Preen, David B. and Bulsara, Max and Semmens, James and Roughead, Elizabeth E. 2013. From the city to the bush: Increases in patient co-payments for medicines have impacted on medicine use across Australia. Australian Health Review. 37 (1): pp. 4-10.
    Source Title
    Australian Health Review
    DOI
    10.1071/AH11129
    ISSN
    0156-5788
    URI
    http://hdl.handle.net/20.500.11937/18814
    Collection
    • Curtin Research Publications
    Abstract

    Aim: To determine whether the national declines in prescription medicine use occurring after the 2005 21% increase in co-payments affected all areas of Australia or were specific to remote and disadvantaged areas. Methods: Observed dispensing of proton pump inhibitors (PPIs) and statins were obtained for 1392 statistical local areas (SLA) of Australia in 2004 and 2006. Expected dispensing was based on national dispensing rates and was age standardised to each SLA. Expected dispensing for 2006 was based on pre-2005 prescription trends. Ratios of observed to expected dispensing (dispensing ratios) for each SLA were calculated. Mean dispensing ratios for each medicine and year were calculated for all remoteness and disadvantage groups. Generalised regression models compared the percentage change in dispensing ratios from 2004 to 2006. Results: Between 2004 and 2006 PPI dispensing fell significantly in major cities (-13.7%, 95% CI = –17.3–9.8), inner regional (-14.0, 95%CI =-19.5–8.2), outer regional (-14.6%, 95%CI =-19.9–9.0) and remote areas (-9.4%, 95%CI =-16.4–1.8). Statin dispensing fell in all groups but the most remote (range 6–7%). When focussing on disadvantage, PPI dispensing fell significantly in all groups (range 12–15%). Statins dispensing did not fall significantly in the most disadvantaged areas (-2.9%, 95%CI =-8.6–3.2) but did in the least (-6.5%, -11.3--1.5) and second-least (-5.8, -10.5--0.9) disadvantaged areas. Dispensing of PPIs and statins in the most remote and disadvantaged areas remained substantially below levels expected for Australia after the 21% co-payments increase.Conclusions: The findings suggest that the 2005 21% in patient co-payments adversely affected prescription medicine use in all areas of Australia and was not specific to remote or disadvantaged areas. Indeed, dispensing of statins fell significantly in all but the most remote and disadvantaged areas, and the existing gap in dispensing of PPIs and statins was not widened by the co-payments increase. PPIs, which are used at above-prevalence rates in Australia and have cheaper over-the counter substitutes available, were more sensitive to co-payment increases than were statins.

    Related items

    Showing items related by title, author, creator and subject.

    • Prescription opioid analgesics for pain management in Australia: 20 years of dispensing
      Islam, M.; McRae, I.; Mazumdar, S.; Taplin, S.; McKetin, Rebecca (2016)
      Background: Opioid prescribing/dispensing data can inform policy surrounding regulation by informing trends and types of opioid prescribed and geographic variations. In Australia so far only partial data on dispensing ...
    • Statin-induced myopathy and the benefit of oral administration of coenzyme Q10
      Kurniawan, Dede Indra (2007)
      Background. Muscle cramps are one of the adverse affects suffered by hypercholesterolemia patients who are treated with statins. Besides reducing cholesterol levels, statins also reduce coenzyme Q10 (CoQ10) blood levels. ...
    • Evaluating pharmaceutical policy impacts using interrupted time series analysis: An Australian case study
      Kemp, A.; Preen, D.; Sanfilippo, F.; Glover, J.; Semmens, James; Roughead, E. (2011)
      Determining the impacts of policy on health outcomes is important for policy makers, clinicians and consumers. Interrupted time series analysis is a powerful quasi-experimental method for quantifying change in an outcome ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.